SK4052003A3 - Oral pharmaceutical composition and use thereof - Google Patents

Oral pharmaceutical composition and use thereof Download PDF

Info

Publication number
SK4052003A3
SK4052003A3 SK405-2003A SK4052003A SK4052003A3 SK 4052003 A3 SK4052003 A3 SK 4052003A3 SK 4052003 A SK4052003 A SK 4052003A SK 4052003 A3 SK4052003 A3 SK 4052003A3
Authority
SK
Slovakia
Prior art keywords
layer
pseudoephedrine
pharmaceutically acceptable
tablet
effective amount
Prior art date
Application number
SK405-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Sara Abelaira
Daniel Bianchi
Francisco Gel
Victor Denker
Mabel Fernandez
Vidal Marta Cicconi De
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK4052003(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of SK4052003A3 publication Critical patent/SK4052003A3/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK405-2003A 2000-10-06 2001-09-28 Oral pharmaceutical composition and use thereof SK4052003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121828 2000-10-06
PCT/EP2001/011229 WO2002028373A1 (en) 2000-10-06 2001-09-28 New pharmaceutical compositions containing epinastine and pseudoephedrine

Publications (1)

Publication Number Publication Date
SK4052003A3 true SK4052003A3 (en) 2003-09-11

Family

ID=8170029

Family Applications (1)

Application Number Title Priority Date Filing Date
SK405-2003A SK4052003A3 (en) 2000-10-06 2001-09-28 Oral pharmaceutical composition and use thereof

Country Status (32)

Country Link
EP (1) EP1326586B1 (ko)
JP (1) JP2004521864A (ko)
KR (1) KR20030036894A (ko)
CN (1) CN1291715C (ko)
AR (2) AR032479A1 (ko)
AT (1) ATE424813T1 (ko)
AU (2) AU1229002A (ko)
BG (1) BG107686A (ko)
BR (1) BR0114339A (ko)
CA (1) CA2423288C (ko)
CZ (1) CZ2003945A3 (ko)
DE (1) DE60137952D1 (ko)
EA (1) EA007288B1 (ko)
EC (1) ECSP034513A (ko)
EE (1) EE200300138A (ko)
ES (1) ES2323570T3 (ko)
HK (1) HK1062196A1 (ko)
HR (1) HRP20030259A2 (ko)
HU (1) HUP0300970A3 (ko)
IL (1) IL154884A0 (ko)
ME (1) MEP39708A (ko)
MX (1) MXPA03002900A (ko)
MY (1) MY131159A (ko)
NO (1) NO20031537L (ko)
NZ (1) NZ525653A (ko)
PE (1) PE20020324A1 (ko)
PL (1) PL366123A1 (ko)
SK (1) SK4052003A3 (ko)
UA (1) UA75896C2 (ko)
WO (1) WO2002028373A1 (ko)
YU (1) YU24603A (ko)
ZA (1) ZA200302079B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000264A1 (en) * 2001-06-20 2003-01-03 Schering Corporation Antihistamines for the treatment of nasal congestion and nasal obstruction
JP4549618B2 (ja) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 鼻炎用組成物
WO2004014353A1 (en) * 2002-08-02 2004-02-19 Boehringer Ingelheim International Gmbh Pharmaceutical formulations comprising combinations of epinastine, pseudoephedrine and methylephedrine
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
WO2005079752A2 (en) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
ID26390A (id) * 1997-12-23 2000-12-21 Schering Corp Komposisi untuk pengobatan pernapasan dan penyakit kulit sekurangnya terdiri dari satu leukotrien antagonis dan satu antihistamin
EP1117405A2 (en) * 1998-10-09 2001-07-25 Schering Corporation Composition and method for treating allergic diseases
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
NO20031537L (no) 2003-06-04
MY131159A (en) 2007-07-31
UA75896C2 (en) 2006-06-15
HUP0300970A3 (en) 2005-03-29
EP1326586B1 (en) 2009-03-11
MXPA03002900A (es) 2003-09-10
ZA200302079B (en) 2004-05-05
ECSP034513A (es) 2003-04-25
EA007288B1 (ru) 2006-08-25
NZ525653A (en) 2006-07-28
PE20020324A1 (es) 2002-06-18
KR20030036894A (ko) 2003-05-09
EE200300138A (et) 2003-08-15
AR087240A2 (es) 2014-03-12
CA2423288C (en) 2007-11-13
CN1291715C (zh) 2006-12-27
PL366123A1 (en) 2005-01-24
DE60137952D1 (de) 2009-04-23
AU2002212290B2 (en) 2006-08-03
ATE424813T1 (de) 2009-03-15
HRP20030259A2 (en) 2005-02-28
WO2002028373A1 (en) 2002-04-11
BG107686A (bg) 2003-11-28
EA200300430A1 (ru) 2003-10-30
YU24603A (sh) 2006-05-25
IL154884A0 (en) 2003-10-31
AR032479A1 (es) 2003-11-12
HUP0300970A2 (hu) 2003-11-28
AU1229002A (en) 2002-04-15
HK1062196A1 (en) 2004-10-21
NO20031537D0 (no) 2003-04-04
BR0114339A (pt) 2003-12-09
EP1326586A1 (en) 2003-07-16
CN1468094A (zh) 2004-01-14
ES2323570T3 (es) 2009-07-21
MEP39708A (en) 2011-02-10
CZ2003945A3 (cs) 2003-08-13
CA2423288A1 (en) 2002-04-11
JP2004521864A (ja) 2004-07-22

Similar Documents

Publication Publication Date Title
MXPA00012957A (es) Composicion para dosis oral de liberacion extendida.
RU2614382C2 (ru) Стабильная фармацевтическая композиция для перорального введения, включающая левоцетиризин или его фармацевтически приемлимую соль, и монтелукаст или его фармацевтически приемлимую соль
US7022341B2 (en) Pharmaceutical compositions containing epinastine and pseudoephedrine
US20030228359A1 (en) Pharmaceutical formulations containing epinastine, belladonna, and pseudoephedrine
SK4052003A3 (en) Oral pharmaceutical composition and use thereof
US20060193915A1 (en) Compression coated tablets
US20080095846A1 (en) Pharmaceutical compositions of antihistamine and decongestant
AU2002212290A1 (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
EP1490034B1 (en) Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions
US20050084527A1 (en) Pharmaceutical formulations containing combinations of epinastine, pseudoephedrine, and methylephedrine
US20050008703A1 (en) Medical formulation containing a muscarinic agonist
US20060122194A1 (en) Tablet comprising efletirizine and pseudoephedrine
TWI280884B (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
EP1809255A1 (en) High-dosage extended-release formulation of gepirone
US20060099267A1 (en) High-dosage extended-release formulation of gepirone
KR20060108696A (ko) Ｌｔｂ4 길항제를 함유하는 약제학적 제형, 이의 제조방법및 이의 용도
JP2006509789A (ja) 不安症治療法及び治療薬